tetradecanoylphorbol acetate has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, JH; He, HR; Hu, G; Yao, HH | 1 |
| Borwege, S; Joyce, JN; Millan, MJ; Presgraves, SP | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Inhibitory effects of 1-methyl-4-phenylpyridinium on glutamate uptake into cultured C6 glioma cells.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acid Transport System X-AG; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Glioma; Glutamic Acid; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate | 2004 |
Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antibodies; Benzothiazoles; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Line; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetradecanoylphorbol Acetate; Thiazoles; Tretinoin | 2004 |